The ongoing coronavirus disease 2019 (COVID-19) pandemic is caused by the novel
coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Individuals …

Type 2 diabetes mellitus and hypertension are the most common comorbidities in patients
with coronavirus infections. Emerging evidence demonstrates an important direct metabolic …

Purpose Angiotensin converting enzyme 2 (ACE2) is the door for SARS-CoV-2, expressed
in critical metabolic tissues. So, it is rational that the new virus causes pleiotropic alterations …

Recent studies showed that comorbidities such as diabetes, hypertension and obesity
contribute to severe and worse outcomes of coronavirus disease 2019 (COVID-19) …

Up to 50% of the people who have died from COVID-19 had metabolic and vascular
disorders. Notably, there are many direct links between COVID-19 and the metabolic and …

COVID-19, caused by SARS-CoV-2, is characterized by pneumonia, lymphopenia,
exhausted lymphocytes and a cytokine storm. Several reports from around the world have …

Abstract SARS-CoV-2, the virus responsible for COVID-19, uses angiotensin converting
enzyme 2 (ACE2) as its primary cell-surface receptor. ACE2 is a key enzyme in the counter …

COVID-19 infection has tremendously impacted our daily clinical practice as well as our
social living organization. Virtually all organs and biological systems suffer from this new …

There seems to be a bidirectional interplay between Diabetes mellitus (DM) and coronavirus
disease 2019 (COVID-19). On the one hand, people with diabetes are at higher risk of fatal …

The current COVID-19 pandemic is probably the worst the world has ever faced since the
start of the new millennium. Although the respiratory system is the most prominent target of …